Catalyst Wire Dossier Catalyst Wire Dossier

V3-Cervix

· Immunitor LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V3-Cervix, covering 2019-08-30 to 2019-08-30. Get the full timeline:

Most recent: Clinical Trial Update: Immunotherapy of Cervical Cancer With V3-Cervix [Phase 2]

See pricing